372 related articles for article (PubMed ID: 22937164)
1. Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.
Ali N; Flutter B; Sanchez Rodriguez R; Sharif-Paghaleh E; Barber LD; Lombardi G; Nestle FO
PLoS One; 2012; 7(8):e44219. PubMed ID: 22937164
[TBL] [Abstract][Full Text] [Related]
2. Lack of acute xenogeneic graft- versus-host disease, but retention of T-cell function following engraftment of human peripheral blood mononuclear cells in NSG mice deficient in MHC class I and II expression.
Brehm MA; Kenney LL; Wiles MV; Low BE; Tisch RM; Burzenski L; Mueller C; Greiner DL; Shultz LD
FASEB J; 2019 Mar; 33(3):3137-3151. PubMed ID: 30383447
[TBL] [Abstract][Full Text] [Related]
3. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.
Pino S; Brehm MA; Covassin-Barberis L; King M; Gott B; Chase TH; Wagner J; Burzenski L; Foreman O; Greiner DL; Shultz LD
Methods Mol Biol; 2010; 602():105-17. PubMed ID: 20012395
[TBL] [Abstract][Full Text] [Related]
4. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex.
King MA; Covassin L; Brehm MA; Racki W; Pearson T; Leif J; Laning J; Fodor W; Foreman O; Burzenski L; Chase TH; Gott B; Rossini AA; Bortell R; Shultz LD; Greiner DL
Clin Exp Immunol; 2009 Jul; 157(1):104-18. PubMed ID: 19659776
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells.
Hilger N; Glaser J; Müller C; Halbich C; Müller A; Schwertassek U; Lehmann J; Ruschpler P; Lange F; Boldt A; Stahl L; Sack U; Oelkrug C; Emmrich F; Fricke S
Cytometry A; 2016 Sep; 89(9):803-15. PubMed ID: 27560708
[TBL] [Abstract][Full Text] [Related]
6. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
[TBL] [Abstract][Full Text] [Related]
7. CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.
Laing ST; Griffey SM; Moreno ME; Stoddart CA
J Comp Pathol; 2015; 152(2-3):238-42. PubMed ID: 25670669
[TBL] [Abstract][Full Text] [Related]
8. Increased splenic human CD4
Geraghty NJ; Belfiore L; Adhikary SR; Alexander SI; Sluyter R; Watson D
Transpl Immunol; 2019 Jun; 54():38-46. PubMed ID: 30743002
[TBL] [Abstract][Full Text] [Related]
9. Establishment of Humanized Mice from Peripheral Blood Mononuclear Cells or Cord Blood CD34+ Hematopoietic Stem Cells for Immune-Oncology Studies Evaluating New Therapeutic Agents.
Verma B; Wesa A
Curr Protoc Pharmacol; 2020 Jun; 89(1):e77. PubMed ID: 32453514
[TBL] [Abstract][Full Text] [Related]
10. Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.
Covassin L; Laning J; Abdi R; Langevin DL; Phillips NE; Shultz LD; Brehm MA
Clin Exp Immunol; 2011 Nov; 166(2):269-80. PubMed ID: 21985373
[TBL] [Abstract][Full Text] [Related]
11. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes.
Berney T; Molano RD; Pileggi A; Cattan P; Li H; Ricordi C; Inverardi L
Transplantation; 2001 Jul; 72(1):133-40. PubMed ID: 11468548
[TBL] [Abstract][Full Text] [Related]
12. Increased P2X7 expression in the gastrointestinal tract and skin in a humanised mouse model of graft-versus-host disease.
Cuthbertson P; Adhikary SR; Geraghty NJ; Guy TV; Hadjiashrafi A; Fuller SJ; Ly D; Watson D; Sluyter R
Clin Sci (Lond); 2020 Jan; 134(2):207-223. PubMed ID: 31934722
[TBL] [Abstract][Full Text] [Related]
13. Delayed onset of graft-versus-host disease in immunodeficent human leucocyte antigen-DQ8 transgenic, murine major histocompatibility complex class II-deficient mice repopulated by human peripheral blood mononuclear cells.
Büchner SM; Sliva K; Bonig H; Völker I; Waibler Z; Kirberg J; Schnierle BS
Clin Exp Immunol; 2013 Aug; 173(2):355-64. PubMed ID: 23607364
[TBL] [Abstract][Full Text] [Related]
14. Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.
Covassin L; Jangalwe S; Jouvet N; Laning J; Burzenski L; Shultz LD; Brehm MA
Clin Exp Immunol; 2013 Dec; 174(3):372-88. PubMed ID: 23869841
[TBL] [Abstract][Full Text] [Related]
15. Novel Humanized Peripheral Blood Mononuclear Cell Mouse Model with Delayed Onset of Graft-versus-Host Disease for Preclinical HIV Research.
Holguin L; Echavarria L; Burnett JC
J Virol; 2022 Feb; 96(3):e0139421. PubMed ID: 34818071
[TBL] [Abstract][Full Text] [Related]
16. PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Ry
Burger DR; Parker Y; Guinta K; Lindner D
Biol Blood Marrow Transplant; 2018 Feb; 24(2):260-266. PubMed ID: 29128556
[TBL] [Abstract][Full Text] [Related]
17. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
[TBL] [Abstract][Full Text] [Related]
18. Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.
Fujii H; Luo ZJ; Kim HJ; Newbigging S; Gassas A; Keating A; Egeler RM
PLoS One; 2015; 10(7):e0133216. PubMed ID: 26176698
[TBL] [Abstract][Full Text] [Related]
19. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease.
Bruck F; Belle L; Lechanteur C; de Leval L; Hannon M; Dubois S; Castermans E; Humblet-Baron S; Rahmouni S; Beguin Y; Briquet A; Baron F
Cytotherapy; 2013 Mar; 15(3):267-79. PubMed ID: 23265769
[TBL] [Abstract][Full Text] [Related]
20. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
